Holdings (31)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 10.78% |
| Suven Pharmaceuticals Ltd. | Healthcare | Equity | 9.49% |
| Cipla Ltd. | Healthcare | Equity | 8.55% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 7.98% |
| Globus Medical Inc | Healthcare | Forgn. Eq | 5.58% |
| Gland Pharma Ltd. | Healthcare | Equity | 4.86% |
| Laurus Labs Ltd. | Healthcare | Equity | 4.51% |
| Alembic Pharmaceuticals Ltd. | Healthcare | Equity | 4.38% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.27% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 4.03% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 15.73% | 21.37% | 25.63% | 36.41% |
| Category Average | 16.85% | 19.27% | 21.40% | NA% |
| Rank Within Category | 11.00% | 4.00% | 3.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.63%
Inclusive of GST
Exit load
Exit load of 0.50% if redeemed within 1 month.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Fund management
Education
Mr. Dagli has done B. COM and Chartered Accountant.
Experience
Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
Managed Schemes
HDFC Dual Advantage Fund Series III 1304D August 2016 Direct Growth
HDFC Fixed Maturity Plan 1218 Days December 2016 (1) Direct Growth
HDFC Fixed Maturity Plan 1199 Days January 2017 (1) Direct Growth
HDFC Fixed Maturity Plan 1170 Days February 2017 (1) Direct Growth
HDFC Fixed Maturity Plan 1188 Days March 2017 (1) Direct Growth
HDFC Fixed Maturity Plan 1136 Days June 2017 (1) Direct Growth